NASDAQ:COL.B 6 February 2026

Coloplast A/S stock sinks nearly 8% as Medicare reimbursement change hits Kerecis outlook

Coloplast A/S shares fell 7.82% to 495.35 crowns in Copenhagen after the company slashed its Kerecis growth forecast to 10% due to new U.S. Medicare reimbursement rules. Group revenue for the quarter was flat at 7,043 million crowns, with EBIT before special items down 3% to 1,850 million. Coloplast will phase out Kerecis Shield in Medicare outpatient care and shift focus to its MariGen range.

6 February 2026

NASDAQ:COL.B·Stock Market

Oracle Shares Fall on $20 Billion Fundraising; Navan, Anterix, Driven Brands Beat Estimates
June 12, 2026, 7:12 AM EDT. Oracle Corp (ORCL) shares dropped 8.5% after announcing a $20 billion equity and debt raise to fund AI development, alongside reporting annual negative free cash flow. Meanwhile, Navan Inc (NAVN) surged 8.4% after beating first-quarter fiscal 2027 adjusted earnings estimates with $0.08 per share compared to a loss of $0.01. Anterix Inc (ATEX) shares jumped 25.7% after posting a narrower adjusted loss than expected for Q4 fiscal 2026. Driven Brands Holdings Inc (DRVN) rose 2.1% following better-than-expected adjusted earnings per share of $0.30. These moves highlight shifting investor focus amid the ongoing AI expansion beyond major infrastructure players.

Lloyds Share Price Rises as Buyback, Branch Cuts and July Strategy Update Draw Investor Focus

12 June 2026

Lloyds shares jumped 3.71% to 101.8p, outperforming the FTSE 100, after a fresh buyback filing and news of 79 more branch closures, with investors eyeing the July 30 half-year results and strategy update as the next major catalyst.

OpenAI and Anthropic IPO talk grows as SpaceX sticks to $75 billion mark

12 June 2026

SpaceX’s $75 billion IPO sets a $1.77 trillion valuation benchmark as it prepares to begin Nasdaq trading Friday, more than doubling Saudi Aramco’s 2019 record and making SpaceX one of the most valuable U.S.-listed companies, with the first sessions expected to influence how investors and bankers approach upcoming OpenAI and Anthropic IPOs.

AST SpaceMobile Stock Jumps Before June 17 BlueBird Launch as SpaceX IPO Tests Space Trade

12 June 2026

AST SpaceMobile surged 11.73% to $97.56 after a volatile week, with investors eyeing the June 17 Falcon 9 launch of BlueBird 8, 9, and 10 as the next key catalyst; a successful launch could rebuild confidence after setbacks, but execution delays, losses, and competition keep the stock risky at current levels.

NASDAQ:COL.B 6 February 2026

Coloplast A/S stock sinks nearly 8% as Medicare reimbursement change hits Kerecis outlook

Stock Market Today

Latest articles

Lloyds Share Price Rises as Buyback, Branch Cuts and July Strategy Update Draw Investor Focus

OpenAI and Anthropic IPO talk grows as SpaceX sticks to $75 billion mark

AST SpaceMobile Stock Jumps Before June 17 BlueBird Launch as SpaceX IPO Tests Space Trade

Latest Videos